GlassScriptPhysician profile
Rodolfo E Alcedo
NPI 1316141534
$37,930.14
in general payments reported to CMS, 2019-2025
17 companies · $8,347 in 2025
The $8,347 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,236 · 2020: $449 · 2021: $2,336 · 2022: $1,039 · 2023: $4,553 · 2024: $20K · 2025: $8,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $4,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $16,416.47 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,000.00 |
| Food and Beverage | $4,453.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $31,880.46 | 2019-2025 | Penumbra System, Red 72, Smart Coil |
| Medtronic, INC. | $2,977.75 | 2019-2025 | Pipeline, Solitaire X, Vantage Anterior Fixation System |
| Siemens Medical Solutions USA, INC. | $1,858.98 | 2020-2022 | |
| Imperative Care, INC | $175.00 | 2025 | Zoom Reperfusion Catheter |
| Carl Zeiss Meditec USA, INC. | $157.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $138.54 | 2019-2023 | Xarelto |
| Olympus Latin America, INC. | $136.36 | 2025 | Orbeye Surgical Microscope |
| Medexus Pharma, INC. | $122.22 | 2022 | |
| Globus Medical, INC. | $106.05 | 2025 | Excelsius Gps |
| Microvention, INC. | $103.50 | 2019 | |
| Genzyme Corporation | $89.95 | 2022 | |
| Stryker Corporation | $70.34 | 2023 | Spy-Phi System |
| Johnson and Johnson International | $38.24 | 2023-2024 | Emboguard, Cerebase, Embotrap |
| Astrazeneca Pharmaceuticals LP | $23.69 | 2023 | Andexxa |
| Elekta, INC. | $18.55 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.66 | 2022 | |
| Chiesi USA, INC. | $15.85 | 2023 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodolfo Alcedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.